日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comprehensive assessment of homologous recombination deficiency via simultaneous methylation and mutation analysis in epithelial ovarian cancer: implications for PARP inhibitors efficacy

通过同时进行甲基化和突变分析,全面评估上皮性卵巢癌中的同源重组缺陷:对PARP抑制剂疗效的影响

Dong, Lin; Wu, Huanwen; Li, Ning; Li, Wenbin; Song, Yan; Xiong, Yuanyuan; Yin, Huan; Fang, Huan; Chen, Rongrong; Yi, Xin; Huang, Jie; Ying, Jianming

Single-cell imaging analysis, therapeutic modeling and a Phase Ib trial validate BCL-2 as a target across heterogeneous castration-resistant prostate cancer

单细胞成像分析、治疗模型和 Ib 期试验证实 BCL-2 是异质性去势抵抗性前列腺癌的治疗靶点。

Jamroze, Anmbreen; Liu, Xiaozhuo; Hou, Surui; Jess Li, Wen; Yu, Han; Tracz, Amanda; Jacobi, Justine; Li, Qiuhui; Nastiuk, Kent; Chen, Xin; Huang, Jiaoti; Lin, Kevin; Liu, Mingyu; Cai, Changmeng; Lu, Yue; Puzanov, Igor; Kirk, Jason S; Chatta, Gurkamal; Tang, Dean G

HDAC inhibitor tucidinostat and metronomic capecitabine plus endocrine therapy for patients with HR-positive HER2-negative advanced breast cancer after CDK4/6 inhibitors treatment: clinical findings and exploratory circulating tumor cell and ctDNA biomarker analyses of a multicenter, phase 2 study (SYSUCC-020 trial)

HDAC抑制剂tucidinostat和节拍式卡培他滨联合内分泌治疗用于CDK4/6抑制剂治疗后HR阳性HER2阴性晚期乳腺癌患者:一项多中心2期研究的临床结果和探索性循环肿瘤细胞和ctDNA生物标志物分析(SYSUCC-020试验)

Wu, Huai-Liang; Xia, Wen; Xu, Zhengyang; Zhou, Hanxing; Chen, Limin; Lu, Yongkui; Liu, Xinlan; Pang, Danmei; Liu, Yan; Lu, Qianyi; Xu, Fei; An, Xin; Huang, Jiajia; Jiang, Kuikui; Zhang, Jingmin; Cai, Yili; Hong, Ruoxi; Zheng, Qiufan; Wang, Shusen

Novel Insights Into the Association Between Parkinson's Disease and Constipation: Role of SHMT2 as a Promising Biomarker

帕金森病与便秘关联的新见解:SHMT2作为一种有前景的生物标志物的作用

Ding, Huanxin; Liu, Chuxuan; Sun, Qing; Jiang, Yue; Xu, Qian; Zhu, Zhenguo; Jin, Xin; Huang, Qibo; Li, Yue; Song, Yingchao; Liu, Zenglin; Yu, Tianming; Shi, Bowen; Tan, Delin; Li, Linzehao; Mentch, Frank; Glessner, Joseph; Chang, Xiao; Hakonarson, Hakon; Zhang, Guangyong; Su, Jiehua; Huang, Kaixun; Jing, Xiuna; Liu, Xiaohuan; Wen, Cheng; Geng, Rulin; Lai, Zhuoying; Ruan, Zhijia; Zhan, Yiqiang; Lin, Danyu; Tao, Enxiang

Evolution of Multivalent Aptamer Corona for High-Throughput Multiplexed Detection of Multiple Cancers

用于高通量多重检测多种癌症的多价适体冠的演化

Wang, Mengjie; Jin, Baichuan; Dai, Xin; Huang, Haozhe; Liu, Qiqi; Zhu, Jianqing; Ju, Haixing; Chen, Qixun; Song, Yongmei; Tan, Weihong; Liu, Yuan

Reconfigurable Acoustofluidic Microvortices for Selective Microcargo Delivery

用于选择性微型货物输送的可重构声流体微涡旋

Wang, Lei; Wu, Yiqiang; Tang, Yiyang; Wei, Hui; Lyu, Tianshi; Zhang, Xin; Huang, Tian-Yun

Inhibiting Liver-Derived C3 Protein Rescues Anesthesia/Surgery-Induced Cognitive Impairment, Synaptic Disorders, and Microglial Phagocytosis.

抑制肝脏来源的 C3 蛋白可挽救麻醉/手术引起的认知障碍、突触紊乱和小胶质细胞吞噬作用。

Wu Qianqian, Cong Peilin, Li Zhouxiang, Zhang Yuxin, Wu Huanghui, Zhang Qian, Li Yawei, Tian Li, Miao Qingyuan, Zheng Yinggang, Zhang Hui, Chen Qian, Feng Enduo, Li Xinyang, Chen Zheping, Wang Dong-Xin, Huang Xinwei, Xiong Lize

Steric regulation of CRISPR/Cas12a trans-cleavage kinetics via split-activator extensions

通过分裂激活子延伸对 CRISPR/Cas12a 反式切割动力学进行空间调控

Zhang, Jianhong; He, Xin; Huang, Jing; Cheng, Cheng; He, Guowei; Xia, Ruili; Yang, Jun; Chen, Jianmei; Guo, Lirong; Xiang, Debing; Li, Feng; Shi, Jing; Li, Pu

CRISPR/Cas9 screening with destabilized bicistronic fluorescent protein reporter revealed PABPN1 as a hub of regulators for alternative polyadenylation.

利用不稳定的双顺反子荧光蛋白报告基因进行 CRISPR/Cas9 筛选,发现 PABPN1 是替代多聚腺苷酸化的调节中心。

Hu Zhijie, Liu Yuchi, Han Yuting, Li Mengxia, Deng Ke, Lu Xin, Huang Yingye, Liang Cheng, Wang Yonghua, Fu Yonggui, Xu Anlong

Antimycin A inhibits alpha-herpesvirus replication by disrupting the formation of pyrimidinosomes

抗霉素A通过破坏嘧啶体的形成来抑制α-疱疹病毒的复制。

Guo, Yong-Qi; Wang, Meng-Hang; Tang, Ning; Zhao, Yu-Bo; Wo, Li-Jing; Liang, De-Xin; Huang, Rui; Tang, Yan-Dong; Sun, Ying-Jie; Yin, Xin